ASKLEP’s business domain actualizes an environment in which effective new medications are released and may be used safely by patients in need. Based on this business, we feel that all processes that contribute to pharmaceutical R&D, from consulting on development strategy to post-marketing surveillance, fall under the scope of “drug development”. To utilize to the maximum extent the development functions that make up ASKLEP’s core business (monitoring, data management, and biostatistical analysis), we have become a total solution company serving the drugl development industry.

Beyond these activities, ASKLEP intends to further enhance our vision by evolving into a “Partner Research Organization” (PRO). Focusing on medical and drug development, our vision as a PRO makes us a partner with our clients as we go beyond the traditional Contract Research Organization (CRO) boundaries.